Dashboard
Manage Tickers

STKL SunOpta Inc.

Nasdaq sunopta.com


$ 5.80 $ 0.09 (1.58 %)    

Wednesday, 15-Oct-2025 15:59:53 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 602.61 $ 4.22 (0.71 %)
DIA $ 463.04 $ 0.00 (0 %)
SPY $ 665.11 $ 2.94 (0.44 %)
TLT $ 90.76 $ -0.20 (-0.22 %)
GLD $ 387.41 $ 6.60 (1.73 %)
$ 5.8
$ 5.75
$ 5.15 x 351
$ 6.05 x 100
$ 5.73 - $ 5.86
$ 3.65 - $ 8.11
488,353
na
685.48M
$ 1.06
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-06-2025 06-28-2025 10-Q
2 05-07-2025 03-29-2025 10-Q
3 02-26-2025 01-01-1970 10-K
4 11-05-2024 09-28-2024 10-Q
5 08-07-2024 06-29-2024 10-Q
6 05-08-2024 03-30-2024 10-Q
7 02-28-2024 12-30-2023 10-K
8 11-09-2023 09-30-2023 10-Q
9 08-10-2023 07-01-2023 10-Q
10 05-10-2023 04-01-2023 10-Q
11 03-01-2023 12-31-2022 10-K
12 11-10-2022 10-01-2022 10-Q
13 08-11-2022 07-02-2022 10-Q
14 05-12-2022 04-02-2022 10-Q
15 03-02-2022 01-01-2022 10-K
16 11-10-2021 10-02-2021 10-Q
17 08-11-2021 07-03-2021 10-Q
18 05-12-2021 04-03-2021 10-Q
19 03-03-2021 01-02-2021 10-K
20 10-30-2020 09-26-2020 10-Q
21 08-05-2020 06-27-2020 10-Q
22 05-06-2020 03-28-2020 10-Q
23 02-27-2020 12-28-2019 10-K
24 11-06-2019 09-28-2019 10-Q
25 08-08-2019 06-29-2019 10-Q
26 05-09-2019 03-30-2019 10-Q
27 02-27-2019 12-29-2018 10-K
28 11-07-2018 09-29-2018 10-Q
29 08-08-2018 06-30-2018 10-Q
30 05-09-2018 03-31-2018 10-Q
31 03-01-2018 12-30-2017 10-K
32 11-08-2017 09-30-2017 10-Q
33 08-09-2017 07-01-2017 10-Q
34 05-10-2017 04-01-2017 10-Q
35 03-02-2017 12-31-2016 10-K
36 11-09-2016 10-01-2016 10-Q
37 08-10-2016 07-02-2016 10-Q
38 05-11-2016 04-02-2016 10-Q
39 03-09-2016 01-02-2016 10-K
40 11-12-2015 10-03-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

sunopta-raises-fy2025-sales-guidance-from-788000m-805000m-to-805000m-815000m-vs-794955m-est
SunOpta Raises FY2025 Sales Guidance from ...
08/06/2025 21:02:54

sunopta-q2-adj-eps-004-beats-003-estimate-sales-191489m-beat-186119m-estimate
SunOpta Q2 Adj. EPS $0.04 Beats $0.03 Esti...
08/06/2025 21:02:08

Core News & Articles
Earnings Scheduled For August 6, 2025
08/06/2025 08:33:21

crude-oil-gains-over-2-us-foods-posts-downbeat-earnings
Crude Oil Gains Over 2%; US Foods Posts Do...
05/08/2025 16:46:42

groupon-posts-upbeat-earnings-joins-axon-enterprise-warner-bros-discovery-mercadolibre-and-other-big-stocks-moving-higher-on-thursday
Groupon Posts Upbeat Earnings, Joins Axon ...
05/08/2025 14:11:47

sunopta-announces-share-repurchase-authorization-of-up-to-25m
SunOpta Announces Share Repurchase Authori...
05/07/2025 21:02:26

sunopta-raises-fy2025-sales-guidance-from-77500m-80500m-to-78800m-80500m-vs-78669m-est
SunOpta Raises FY2025 Sales Guidance from ...
05/07/2025 21:01:43

SunOpta (NASDAQ:STKL) raises FY2025 sales outlook from $775.00 million-$805.00 million to $788.00 million-$805.00 million vs $7...

sunopta-q1-adj-eps-004-beats-001-estimate-sales-20160m-beat-19455m-estimate
SunOpta Q1 Adj. EPS $0.04 Beats $0.01 Esti...
05/07/2025 21:01:14

SunOpta (NASDAQ:STKL) reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate of $0.01 by 300 ...

Core News & Articles
Earnings Scheduled For May 7, 2025
05/07/2025 08:33:08

utz-brands-gets-analyst-upgrade-as-salty-snacks-gain-traction-promotions-ease
Utz Brands Gets Analyst Upgrade As Salty S...
04/24/2025 19:28:21

Utz Brands upgraded to Buy as analyst cites share gains, supply chain wins, and easing promo pressure in salty snack market. ...

sunopta-sees-fy2025-sales-775000m-805000m-vs-78896m-est
SunOpta Sees FY2025 Sales $775.000M-$805.0...
02/26/2025 22:02:51

SunOpta (NASDAQ:STKL) sees FY2025 sales of $775.000 million-$805.000 million vs $788.96 million analyst estimate.

sunopta-q4-adj-006-beats-005-estimate-sales-19391m-beat-19163m-estimate
SunOpta Q4 Adj $0.06 Beats $0.05 Estimate,...
02/26/2025 22:01:18

SunOpta (NASDAQ:STKL) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $0.05 by 20 p...

earnings-scheduled-for-february-26-2025
Earnings Scheduled For February 26, 2025
02/26/2025 08:32:32

stephens--co-reiterates-overweight-on-sunopta-maintains-10-price-target
Stephens & Co. Reiterates Overweight on Su...
01/02/2025 12:18:07

Stephens & Co. analyst Jim Salera reiterates SunOpta (NASDAQ:STKL) with a Overweight and maintains $10 price target.

stephens--co-maintains-overweight-on-sunopta-raises-price-target-to-10
Stephens & Co. Maintains Overweight on Sun...
11/06/2024 18:37:54

Stephens & Co. analyst Jim Salera maintains SunOpta (NASDAQ:STKL) with a Overweight and raises the price target from $9 ...

sunopta-q3-2024-adj-eps-002-inline-sales-176216m-beat-173478m-estimate
SunOpta Q3 2024 Adj. EPS $0.02, Inline, Sa...
11/05/2024 22:07:08

SunOpta (NASDAQ:STKL) reported quarterly earnings of $0.02 per share which met the analyst consensus estimate. The company rep...

sunopta-affirms-fy2024-sales-guidance-from-71000m-73000m-to-71000m-73000m
SunOpta Affirms FY2024 Sales Guidance from...
11/05/2024 22:04:43

SunOpta (NASDAQ:STKL) affirms FY2024 sales outlook from $710.00 million-730.00 million to $710.00 million-730.00 million.

da-davidson-maintains-buy-on-sunopta-maintains-9-price-target
DA Davidson Maintains Buy on SunOpta, Main...
10/10/2024 15:43:43

DA Davidson analyst Brian Holland maintains SunOpta (NASDAQ:STKL) with a Buy and maintains $9 price target.

terns-pharmaceuticals-boeing-tesla-and-other-big-stocks-moving-higher-on-monday
Terns Pharmaceuticals, Boeing, Tesla And O...
09/09/2024 14:13:07

sunopta-q2-2024-adj-eps-004-beats-000-estimate-sales-171000m-beat-158927m-estimate
SunOpta Q2 2024 Adj. EPS $0.04 Beats $0.00...
08/07/2024 21:34:19

SunOpta (NASDAQ:STKL) reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate of $0.00 by Infi...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION